NCT06304974 2026-04-17A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)Sichuan Baili Pharmaceutical Co., Ltd.Phase 3 Active not recruiting497 enrolled
NCT03957590 2026-04-13A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell CarcinomaBeOne MedicinesPhase 3 Completed370 enrolled 17 charts